On the other hand, mutations in MEN1 were gained in KMT2A-rearranged ALL cells that became resistant to revumenib by prolonged exposure, indicating that the acquisition of MEN1 mutations plays an important role in acquired revumenib resistance in KMT2A-rearranged ALL. This evidence concerns the gene MEN1 and acute lymphoblastic leukemia.